Chemicals in July and August, Second Quarter and First Half Figures Were Presen- Ted
Total Page:16
File Type:pdf, Size:1020Kb
9/2012 September Materials Solutions Locations Dow Corning’s new Solar Energy THE NEWSPAPER FOR THE European Chemical Industry Exploration and Development Parks and their Operators Face Research Center in Belgium. CHEMICAL AND Great Challenges. Page 6 LIFE SCIENCE MARKETS Pages 10, 11 N EWSFLOW Locations European chemical industry parks and their operators are facing great Supply Chain Management Weighs Heavy challenges; increasing and com- plex demands of globally active The Pharmaceutical Ingredients and Custom Synthesis Industry Prepares for Future Pharma Market Challenges chemical companies on the one hand, ongoing global competition among chemical industry parks on the other. In an overview on Euro- pean chemical industry parks the pros and cons are discussed. Kokkola, one of Finland’s Industrial Parks is Scandinavia’s biggest che- Jean-Luc Herbeaux Roger Laforce Marianne Späne mical manufacturing site is presen- Head of Health Care Business, CEO, Zach System EVP Global Business Development, ted in this issue. Evonik Marketing and Sales, Siegfried More on Pages 10, 11, 12 ▶ Pharmaceutical companies today The pharma industry and its entire Streamlined operations via CPhI 2012 Madrid will be hosting this year’s need an agile, reliable and empower- supply chain are undergoing a lean manufacturing practices CPhI Worldwide Event, from Octo- “ “ “ ing partner with global resources” to paradigm change considering the” are today’s standard which is” ber 9-11. The global pharmaceuti- increase efficiency and keep them on increasing importance of emerging increasing the demand for contract cal ingredients industry is meeting; trying to stay informed about the the cutting edge of technology. countries now also seen as markets. manufactured drugs. latest industry trends and remain one step ahead of a rapidly chan- ging pharmaceutical market. We inquired opinions of some of the market players to hear the newest trends first hand. More on Pages 13, 14, 15 ▶ Pharma Second quarter and first half © pixelfabrik - Fotolia.com reports of “Big Pharma” players Elliott Berger showed that the crisis hit phar- Dr. Peter Pojarliev Alexander R. Wessels Vice President, Global Marketing maceuticals earlier than chemi- Director, Business Development, CEO, DSM Pharmaceutical and Strategy, Catalent Pharma Solutions cals. While France’s Sanofi a pro- Euticals Products jected 2012 sales loss, UK’s Glaxo SmithKline (GSK) has trimmed its outlook. Further companies pre- Among strategic partners open As global supply chains expand, the Partnering and open innovation sented in our pharmaceuticals “communication and common under- “safety of ingredients and finished “models are clearly becoming more overview are AstraZeneca, No- ” ” ” standing of the project goals and drugs, as well as the sustainability of significant in the drug development vartis, Bayer, Pfizer, Merck & Co, Bristol-Myers Squibb. expectations are key success factors. these supply chains, become critical. and delivery space as well. More on Pages 2, 11, 18 ▶ Chemicals In July and August, second quarter and first half figures were presen- ted. For the industry’s majors in particular the numbers published so far this year have been on course or only slightly weaker. Even if che- mical output in the European Uni- on sank by 2.4% year-on-year from January to June, selling prices were Hendrik Baumann David DeCuir Thomas D’Ambra 3.4% higher, Cefic reported. Com- Commercial Director, Director, Albemarle Fine Chairman, CEO & President, panies presented in our chemicals CU Chemie Uetikon Chemistry Services AMRI overview are BASF, Dow Chemical, LyondellBasell, DuPont, Arkema, Suppliers to the pharmaceutical Recent issues in the pharma market Solvay, Rhodia, Bayer. As the custom synthesis market industry will be required to make coinciding with prolonged economic More on Pages 9, 20, 22, 24 ▶ “is extremely diversified, we will “ “ ” smaller campaigns of multiple drugs” recession in Western countries ”are probably see a market consolidation in their facilities rather than large leading to changes in how pharma in the next years. campaigns or even dedicated lines. companies consider outsourcing. Read the related article and the complete statements in the Pharma section on pages 14/15. © pixelfabrik - Fotolia.com ntgelt bezahlt · 78719 ntgelt E READER SERVICE Research & Development, Production and Distribution of API worldwide. Don’t have your own CHEManager Europe? Wrong address? CPhI Worldwide 2012 Send an e-mail to 9 - 11 October, Madrid chemanager-europe@ Learn more at booth 8D18 gitverlag.com · PF 11 05 64 · 69469 Weinheim · Pressepost · DPAG· · DPAG· · Pressepost Weinheim · PF 11 05 64 69469 Under control of WILEY VCH WILEY chemanager-online.com/en Page 2 MARKETS & COMPANIES CHEManager Europe 9/2012 CONTENT DECISIVE INFORMATION THE PORTAL AND NEWSPAPER FOR THE EUROPEAN CHEMICALS AND PHARMACEUTICAL MARKETS Front Page Pharma Chemical Ireland Strategy on Track 12 Austerity Measures Bite 18 Long Term Solutions Counteract Wide Range of Challenges The European Pharmaceuticals Economy Supply Chain Management Weighs Heavy 1, 14-15 Matt Moran, Director, PharmaChemical Ireland Dede Williams, Freelance Journalist The Pharmaceutical Ingredients and Custom Synthesis Industry Prepares for Future Pharma Market Challenges Nordic Clustering 12 The Kokkola Industrial Park is Scandinavia’s biggest Production 19–21 Chemical Manufacturing Site Markets & Companies 2–9 The Most Trusted Advisor 19 Emerson’s Steve Sonnenberg on the Importance of Trust The Best of Both Worlds 4 Pharma 13–18 Supply Chain Management Organisations Developing in Business Relations Towards a Coordinated Network Model Interview with Steve Sonnenberg, Vice President of Emerson ¡Bienvenidos a la Feria! 13 and President of Emerson Process Management CPhI Worldwide, the Leading Annual Networking Event of the Contract Manufacturing in India and China 5 Global Pharmaceutical Ingredients Industry, Returns to Madrid Government Policies Encourage Outsourcing of Western Interview with Andrew Pert, Brand Director CPhI Worldwide, Scrum in the Regulated Environment 20 Pharma Industry ICSE, P-MEC Europe, InnoPack, UBM Live Opportunity or Risk for Computer Systems Validation? Ayelt Komus, Professor, Koblenz University of Applied Sciences; Sabine A Showcase for Energy Efficiency 6 Komus, consultant with IDS Scheer Consulting and lecturer at the Kob- Materials Solutions Help makeSolar Energy a Competitive Changing Times 14, 15 Alternative to Traditional Energy Sources Pharmaceutical Supply Chain Experts Discuss Challenges Arising lenz University of Applied Sciences; Paul Noble, consultant, IQC Group Interview with Eric Peeters, Vice President, Solar Solutions & Wind Energy from a Changing Pharma Business Model Solutions, Dow Corning Interviews with Jean-Luc Herbeaux, Evonik; Roger Laforce, Zach System; Optimization of Product Protection 21 Marianne Späne, Siegfried; Alexander R. Wessels, DSM Pharmaceutical Implementation of Improved Hygiene Zones at Swiss DSM Fine China 7 Products; Hendrik Baumann, CU Chemie Uetikon; Elliott Berger, Catalent Site in Sisseln The Future of Fine Chemical Production Pharma Solutions; David DeCuir, Albemarle Fine Chemistry Services; Dr. Wolfgang Müller, Managing Director, Chemgineering Dr. Kai Pflug, CEO, Management Consulting and Dr. Bernhard Thomas D’Ambra, AMRI; Dr. Peter Pojarliev, Euticals Hartmann, Managing Director, A.T. Kearney China © Nmedia/fotolia.com Thriving Generics 16 Chemicals 22 What’s Up For Sale? 8 Patent Cliff Revenues Fertilize Generics Companies M&A in the Chemicals & Materials Sector Dr. Jerry Isaacson, Head of Global Data Healthcare Industry Dynamics Carolyn Buller, Partner, and Global Chemicals Industry Group Leader, On a Sound Basis in Line with the Current Trends 22 online.com/en Sepawa 2012: On a Growth Course with Numerous Innovations chemanager - Squire Sanders No Experimenting 16 Stick to Your Strengths with Biosimilars chemanager - The Latest from Socma 8 Hard Wood with a Soft Core 22 Expect More 17 online.com /en The Industry’s Pulse at Half-time 9 Siegfried Promises to Deliver on its Slogan as the Company The Chemicals Economy People · Publications · Events 23 Dede Williams, Freelance Journalist Keeps Adding Pieces to its Puzzle of Offerings Interviews with Marianne Späne, the company’s Executive Vice Presi- www.gitverlag.com dent, Global Business Development, Sales and Marketing, Siegfried Locations 10–12 At A Glance 24 HPAPIs and ADC Toxins 18 European Chemical Industry Parks 2.0 10, 11 Manufacturing Challenges for the Targeted Drugs of Tomorrow Index 24 Insights from Global Benchmarking Aline Devoille, marketing manager – synthetic molecules and Jean- Christoph Behrendt, Scopein Management Consultants François Marcoux, technical business development manager, Novasep Imprint 24 Lanxess Rises into German Warwick Reaches Agreement BASF Included in Three Indices Stock Index DAX to Acquire IDC BASF was again included in the tection. In the current ranking, the global Dow Jones Sustainability In- Carbon Disclosure Leadership Index Warwick Chemicals, a manufac- a bleach activator used in laundry dex (DJSI World). The company has (CDLI) listed BASF with an outstand- turer of detergent chemicals for the and household product applica- been recognized for its sustainabil- ing place for the eighth time and the laundry and home care market, has tions. The business was acquired ity engagement in areas such as cli- company has been included in the reached an agreement to purchase by Dubag in February 2011 from